Home / Founders / Kevin Marks

Kevin Marks

Founder of Delphia Therapeutics

Kevin Marks

Backed by

Polaris Partners
Dave Barrett
Jon Flint

Sources

Delphia Therapeutics Scores $67 Series A — 2024-05

Browse all founders · Browse investors